Table 2.
KM (mM) a | kcat (s−1) a | kcat/KM (mM−1s−1) a | Kd (µM) b | Cellular concentrations c |
|
---|---|---|---|---|---|
Zn2+ | 2.7 ± 0.5 | 341 ± 35 | 126 ± 27 | 7.0 ± 0.9 | fM-nM |
Mn2+ | 0.6 ± 0.1 | 79 ± 8 | 132 ± 26 | 0.6 ± 0.1 | 0.1–10 µM |
Mg2+ | 1.3 ± 0.3 | 31 ± 4 | 24 ± 7 | 82 ± 21 | 500 µM |
Ca2+ | 3.7 ± 0.7 | 48 ± 6 | 13 ± 3 | 566 ± 249 | 0.1–1 µM (resting)/ 1000 µM (stress) |
KM and kcat values are reported for human SMP30 using the substrate gluconolactone and a saturating concentration of the divalent metal ion listed using conditions detailed in the materials and methods.
The reported Kd values were obtained using 10 mM gluconolactone and varying the metal concentration to obtain velocities. A fit of Equation 1 to data shown in Figure 4 yielded the reported values of Kd as detailed in material and methods.
Estimates of physiological concentration of divalent cations were taken from the litterature (34–40).